What are the types and brand names of Progestin-Only Pills (POP), also known as the mini-pill?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Types of Progestin-Only Pills (POPs) and Their Brand Names

Progestin-only pills (POPs), also known as mini-pills, are a type of oral contraceptive that work primarily by thickening cervical mucus rather than inhibiting ovulation, and are available in several formulations with different progestin types and dosages. 1

Types of Progestin-Only Pills

  • Traditional POPs: These contain lower doses of progestins and require strict adherence to timing (must be taken within 3 hours of the same time each day) 1

  • Desogestrel-containing POPs: These newer formulations (75 mcg desogestrel) provide more consistent ovulation inhibition and allow for a 12-hour window for taking the pill, offering efficacy comparable to combined oral contraceptives 2

Common Brand Names

  • Norethindrone-based POPs (traditional):

    • Micronor (0.35 mg norethindrone) 3
    • Nora-BE (0.35 mg norethindrone) 3
    • Camila (0.35 mg norethindrone) 3
    • Errin (0.35 mg norethindrone) 3
  • Desogestrel-based POPs (newer formulation):

    • Slynd (4 mg drospirenone) - a newer POP with a 24-hour missed pill window 2

Effectiveness and Mechanism of Action

  • POPs work primarily by thickening cervical mucus, making it difficult for sperm to reach the egg 1

  • Unlike combined hormonal contraceptives, traditional POPs do not consistently inhibit ovulation, which contributes to their lower effectiveness compared to combined methods 1

  • With typical use, approximately 9 out of 100 women become pregnant in the first year of using POPs 4

  • Desogestrel-containing POPs show higher effectiveness (Pearl index of 0.41 crude, 0.14 adjusted) due to more consistent ovulation inhibition 2

Important Considerations for Use

  • POPs must be taken consistently at the same time each day, with traditional POPs requiring administration within a 3-hour window 1

  • A dose is considered missed if taken more than 3 hours late for traditional POPs 1

  • If a dose is missed, users should:

    • Take one pill as soon as possible
    • Continue taking pills daily at the same time
    • Use backup contraception for 2 consecutive days of correct pill use
    • Consider emergency contraception if unprotected intercourse occurred 1
  • POPs are generally not recommended as first-choice contraceptives for healthy adolescents due to the strict timing requirements and potential for irregular bleeding 1

Side Effects and Management

  • Irregular bleeding is the most common side effect and reason for discontinuation, affecting up to 25% of users 5

  • Bleeding patterns may include:

    • Increased frequency of bleeding
    • Lengthened cycles
    • Breakthrough bleeding
    • Spotting
    • Prolonged bleeding 5
  • Management of bleeding irregularities may include:

    • NSAIDs for 5-7 days of treatment
    • Counseling about expected bleeding patterns 4

Appropriate Candidates for POPs

  • Breastfeeding women (POPs do not affect milk production) 1

  • Women with contraindications to estrogen use, such as:

    • History of venous thromboembolism
    • Hypertension
    • Migraine with aura
    • Age ≥35 years who smoke 1, 6
  • Women in the immediate postpartum period 1

  • Women who require strict adherence to daily pill-taking may be better candidates for longer-acting progestin methods like implants or IUDs 1

Cautions and Follow-up

  • No routine follow-up visit is required after initiating POPs, but women should be advised to return if they experience side effects or want to change methods 1

  • At other routine visits, healthcare providers should:

    • Assess satisfaction with the method
    • Evaluate any health status changes that might affect POP use
    • Consider assessing weight changes if the woman is concerned 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Considerations for the use of progestin-only contraceptives.

Journal of the American Academy of Nurse Practitioners, 2010

Guideline

Management of Side Effects with Progestin-Only Pills

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Progestogen-only pills and bleeding disturbances.

Human reproduction (Oxford, England), 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.